InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ECU | Ann: Change in Substantial Holding (Becamal Pty L | 02/06/10 | 0 | 740 | |||
|
|||||||
ECU | Ann: Change of Director's Interest Notice (C | 02/06/10 | 0 | 510 | |||
|
|||||||
ECU | Ann: Section 708A Notice | 01/06/10 | 0 | 360 | |||
|
|||||||
ECU | Ann: Appendix 3B | 01/06/10 | 0 | 390 | |||
|
|||||||
ECU | Ann: Results of Meeting | 01/06/10 | 0 | 412 | |||
|
|||||||
ECU | Ann: Galilee Acceptance of Offer | 28/05/10 | 0 | 286 | |||
|
|||||||
ECU | profitable nz coal with qld csg paid by agl | 28/05/10 | 2 | 1.0K | |||
|
|||||||
ECU | Ann: Quarterly Cashflow Report and Activities Rep | 10/05/10 | 4 | 913 | |||
|
See All Discussions